COVID cases are continuing to decline in the U.S., however we are beginning to see some increased activity with new variants, particularly BQ.1 and BQ.1.1.
Key Points: COVID In today’s Recommendation for Industry, we discuss the globally increasing respiratory diseases, which we see as likely attributable to annual seasonal trends.
Key Points: COVID In today’s Recommendation for Industry, we discuss the expected fall increase in respiratory illnesses. Read more below. COVID vaccines in pregnancy tied
Key Points: COVID In today’s Recommendation for Industry, we discuss the overall positive trajectory of COVID cases, even with variants continuing to emerge. Read more
Key Points: COVID In today’s Recommendation for Industry, we discuss TAG’s weekly updates on infectious disease and some further advice in reducing norovirus transmission. Read
Key Points: COVID In today’s Recommendation for Industry, we discuss the status of COVID, monkeypox and the flu, and the continuing evolution of TAG’s matrices
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains
Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use
